| Stage | BRK-B | % of rev | UFCS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $102B | 100.00% | $392M | 100.00% | BRK-B ×259.98 |
| Gross profit | $55.9B | 54.87% | $391M | 99.84% | UFCS +45.0pp |
| Operating income | $17.1B | 16.77% | $48M | 12.25% | BRK-B +4.5pp |
| Pre-tax income | $31.8B | 31.25% | $45M | 11.44% | BRK-B +19.8pp |
| Net income | $25.8B | 25.31% | $35M | 8.96% | BRK-B +16.4pp |
| Stage | BRK-B | UFCS | Gap · A − B |
|---|---|---|---|
| Revenue | $102B100.00% | $392M100.00% | BRK-B ×259.98 |
| Gross profit | 54.87%$55.9B | 99.84%$391M | UFCS +45.0pp |
| Operating income | 16.77%$17.1B | 12.25%$48M | BRK-B +4.5pp |
| Pre-tax income | 31.25%$31.8B | 11.44%$45M | BRK-B +19.8pp |
| Net income |
| 25.31%$25.8B |
| 8.96%$35M |
| BRK-B +16.4pp |
None
No disclosed counterparties: BRK-B.